Linh T Nguyen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Linh T Nguyen

Showing results (71-80 of 79) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 79 results.

Elife|April 22, 2020

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanomaKenji Murata, Munehide Nakatsugawa, Muhammed A Rahman, et al.

Cancer Immunology Research|March 14, 2025

CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor MicroenvironmentDouglas C Chung, Noor Shakfa, Jehan Vakharia, et al.

Journal for Immunotherapy of Cancer|March 15, 2019

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.

Cancer Immunology, Immunotherapy : CII|February 13, 2019

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2Linh T Nguyen, Samuel D Saibil, Valentin Sotov, et al.

The Lancet Regional Health. Western Pacific|May 23, 2022

Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trialThuy P Nguyen, Quyet Do, Lan T Phan, et al.

Cancers|January 21, 2023

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon CancerBernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon CancerBernhard Mlecnik, Carlo Bifulco, Gabriela Bindea, et al.

Cancers|September 23, 2022

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC StudyBernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea, et al.

Lancet (London, England)|May 15, 2018

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyFranck Pagès, Bernhard Mlecnik, Florence Marliot, et al.

Pageof 8

Search research articles

Showing results (71-80 of 79) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 79 results.

Elife|April 22, 2020

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanomaKenji Murata, Munehide Nakatsugawa, Muhammed A Rahman, et al.

Cancer Immunology Research|March 14, 2025

CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor MicroenvironmentDouglas C Chung, Noor Shakfa, Jehan Vakharia, et al.

Journal for Immunotherapy of Cancer|March 15, 2019

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.

Cancer Immunology, Immunotherapy : CII|February 13, 2019

The Lancet Regional Health. Western Pacific|May 23, 2022

Cancers|January 21, 2023

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon CancerBernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020

Cancers|September 23, 2022

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC StudyBernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea, et al.

Lancet (London, England)|May 15, 2018

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyFranck Pagès, Bernhard Mlecnik, Florence Marliot, et al.

Pageof 8